InsidersTradesSigma
Discover the full directors' dealings record of 서울바이오시스, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Technology sector, 서울바이오시스 has recorded 1 reports. Market capitalisation: €794.7bn. The latest transaction was disclosed on 10 March 2026 — Other. Among the most active insiders: 서울바이오시스. Every trade is free.
FY ended December 2025 · cache
0 of 0 declarations